Kaliaev Artem, Chavez Wilson, Soto Jorge, Huda Fahimul, Xie Hua, Nguyen Man, Shamdasani Vijay, Anderson Stephan
Boston University Medical Center, Department of Radiology, Boston, MA, USA.
Ultrasound Imaging and Interventions, Philips Research North America, Cambridge, MA, USA.
J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1091-1101. doi: 10.1016/j.jceh.2022.01.007. Epub 2022 Jan 31.
BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is widespread chronic disease of the live in humans with the prevalence of 30% of the United States population. The goal of the study is to validate the performance of quantitative ultrasound algorithms in the assessment of hepatic steatosis in patients with suspected NAFLD.
This prospective study enrolled a total of 31 patients with clinical suspicion of NAFLD to receive liver fat measurements by quantitative ultrasound and reference MRI measurements (proton density fat-fraction, PDFF). The following ultrasound (US) parameters based on both raw ultrasound RF (Radio Frequency) data and 2D B-mode images of the liver were analyzed with subsequent correlation with MRI-PDFF: hepatorenal index, acoustic attenuation coefficient, Nakagami coefficient parameter, shear wave viscosity, shear wave dispersion and shear wave elasticity. Ultrasound parameters were also correlated with the presence of hypertension and diabetes.
The mean (± SD) age and body mass index of the patients were 49.03 (± 12.49) and 30.12 (± 6.15), respectively. Of the aforementioned ultrasound parameters, the hepatorenal index and acoustic attenuation coefficient showed a strong correlation with MRI-PDFF derivations of hepatic steatosis, with -values of 0.829 and 0.765, respectively. None of the remaining US parameters showed strong correlations with PDFF. Significant differences in Nakagami parameters and acoustic attenuation coefficients were found in those patients with and without hypertension.
Hepatorenal index and acoustic attenuation coefficient correlate well with MRI-PDFF-derived measurements of hepatic steatosis. Quantitative ultrasound is a promising tool for the diagnosis and assessment of patients with NAFLD.
背景/目的:非酒精性脂肪性肝病(NAFLD)是一种常见的人类肝脏慢性疾病,在美国人群中的患病率为30%。本研究的目的是验证定量超声算法在评估疑似NAFLD患者肝脂肪变性中的性能。
本前瞻性研究共纳入31例临床怀疑患有NAFLD的患者,通过定量超声和参考MRI测量(质子密度脂肪分数,PDFF)来测量肝脏脂肪。基于原始超声射频(RF)数据和肝脏二维B模式图像的以下超声(US)参数进行了分析,并随后与MRI-PDFF进行相关性分析:肝肾指数、声衰减系数、 Nakagami系数参数、剪切波粘度、剪切波频散和剪切波弹性。超声参数还与高血压和糖尿病的存在情况相关。
患者的平均(±标准差)年龄和体重指数分别为49.03(±12.49)和30.12(±6.15)。在上述超声参数中,肝肾指数和声衰减系数与肝脂肪变性的MRI-PDFF推导值显示出强相关性,相关系数分别为0.829和0.765。其余US参数均与PDFF无强相关性。在有高血压和无高血压的患者中,发现Nakagami参数和声衰减系数存在显著差异。
肝肾指数和声衰减系数与MRI-PDFF得出的肝脂肪变性测量值具有良好的相关性。定量超声是诊断和评估NAFLD患者的一种有前景的工具。